GfK to provide managed care panels

GfK Healthcare launched a new product to provide pharma marketers with the ability to access and query a panel of managed market workers representing the “largest and most influential organizations” in the US, the company said.

The Managed Markets Delegates on Demand tool delivers a quarterly study that marketers can use to examine market events on formulary design, or test new strategies in development. The panels are comprised of 30 individuals, including 20 pharmacy directors and 10 medical directors, according to a statement.

“Overall, clients are being more judicious in the research they are fielding and additionally are repurposing secondary data in order to try to glean the information they need while not incurring additional costs,” said Sue Ramspacher, SVP of GfK's managed markets practice area, in the release. “However, as a result there are a lot of questions…that are being left unanswered.”
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.